Consumers span a broad spectrum of demographics, with 83% using cannabis to help them unwind
Black and African American cancer patients were less likely to get certified for medical cannabis.
Researchers identified a ‘significant decrease’ in financial interactions between opioid manufacturers and physicians as an effect of medical cannabis legalisation.
Black babies were disproportionately more likely to be drug tested than White, before and after cannabis legalisation.
Women, particularly women of colour, are woefully underrepresented in leadership positions across industries—cannabis can do better, and benefit.
New research refutes the theory that cannabis is a ‘gateway drug’.
Researchers found no significant increase in the rates of psychosis-related diagnoses in states which have introduced legalisation.
Researchers found a reduction of 26% in pharmacy-based distribution of codeine in states where cannabis was legal.
In a US survey, 21% of those polled said they were consuming cannabis-based products this month.
The findings have led to calls for more patient-doctor communication around its use in medical care.